MRK Financials: Merck & Co Inc AI Analysis



Financials

MRK Financial

Merck & Co Inc

$135.18

-0.58%

$-0.78

At close: Aug 18, 16:00:00 GMT-4

$144.97

7.24%

$9.78

Pre-market: Aug 19, 07:40:37 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$135.97

Open

$137.24

Day's Range

$134.88 - $144.97

52 week range

$77.58 - $144.97

Volume

8.1M

Avg.Volume

9.9M

Dividend yield

2.73%

EPS (TTM)

1.25

Market Cap

$358.0B

What is MRK?

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Features

Markets

News

Breakdown	TTM	06/30/2026	03/31/2026	12/31/2025	09/30/2025	06/30/2025
Revenue	66,569	16,607	16,286	16,400	17,276	15,806
Revenue Growth (YoY)	5%	5%	5%	5%	4%	-2%
Cost of Revenue	15,124	3,144	3,958	4,239	3,783	3,457
Gross Profit	51,445	13,463	12,328	12,161	13,493	12,349
Selling, General & Admin	11,115	2,887	2,700	2,895	2,633	2,648
Research & Development	29,542	9,736	12,558	3,247	4,001	3,995
Operating Expenses	40,657	12,623	15,258	6,142	6,634	6,643
Other Non Operating Income (Expenses)	769	237	176	204	152	221
Pretax Income	5,948	-683	-3,534	3,420	6,745	4,999
Income Tax Expense	2,779	654	709	458	958	571
Net Income	3,173	-1,335	-4,240	2,963	5,785	4,427
Net Income Growth	-81%	-130%	-183%	-21%	83%	-19%
Shares Outstanding (Diluted)	2,470	2,470	2,472	2,486	2,498	2,513
Shares Change (YoY)	-2%	-2%	-2%	-2%	-2%	-1%
EPS (Diluted)	1.28	-0.54	-1.72	1.19	2.32	1.76
EPS Growth	-80%	-131%	-186%	-20%	87%	-18%
Free Cash Flow	--	--	2,927	1,824	6,835	2,529
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	77.28%	81.06%	75.69%	74.15%	78.1%	78.12%
Operating Margin	16.2%	5.05%	-17.99%	36.7%	39.7%	36.1%
Profit Margin	4.76%	-8.03%	-26.03%	18.06%	33.48%	28%
Free Cash Flow Margin	--	--	17.97%	11.12%	39.56%	16%
EBITDA	--	--	-1,418	8,485	8,013	6,825
EBITDA Margin	--	--	-8.7%	51.73%	46.38%	43.17%
D&A For EBITDA	--	--	1,512	2,466	1,154	1,119
EBIT	10,788	840	-2,930	6,019	6,859	5,706
EBIT Margin	16.2%	5.05%	-17.99%	36.7%	39.7%	36.1%
Effective Tax Rate	46.72%	-95.75%	-20.06%	13.39%	14.2%	11.42%

Breakdown

TTM

06/30/2026

03/31/2026

12/31/2025

09/30/2025

06/30/2025

Revenue

66,569

16,607

16,286

16,400

17,276

15,806

Revenue Growth (YoY)

-2%

Cost of Revenue

15,124

3,144

3,958

4,239

3,783

3,457

Gross Profit

51,445

13,463

12,328

12,161

13,493

12,349

Selling, General & Admin

11,115

2,887

2,700

2,895

2,633

2,648

Research & Development

29,542

9,736

12,558

3,247

4,001

3,995

Operating Expenses

40,657

12,623

15,258

6,142

6,634

6,643

Other Non Operating Income (Expenses)

769

237

176

204

152

221

Pretax Income

5,948

-683

-3,534

3,420

6,745

4,999

Income Tax Expense

2,779

654

709

458

958

571

Net Income

3,173

-1,335

-4,240

2,963

5,785

4,427

Net Income Growth

-81%

-130%

-183%

-21%

83%

-19%

Shares Outstanding (Diluted)

2,470

2,472

2,486

2,498

2,513

Shares Change (YoY)

-2%

-1%

EPS (Diluted)

1.28

-0.54

-1.72

1.19

2.32

1.76

EPS Growth

-80%

-131%

-186%

-20%

87%

-18%

Free Cash Flow

2,927

1,824

6,835

2,529

Free Cash Flow Per Share

Gross Margin

77.28%

81.06%

75.69%

74.15%

78.1%

78.12%

Operating Margin

16.2%

5.05%

-17.99%

36.7%

39.7%

36.1%

Profit Margin

4.76%

-8.03%

-26.03%

18.06%

33.48%

28%

Free Cash Flow Margin

17.97%

11.12%

39.56%

16%

EBITDA

-1,418

8,485

8,013

6,825

EBITDA Margin

-8.7%

51.73%

46.38%

43.17%

D&A For EBITDA

1,512

2,466

1,154

1,119

EBIT

10,788

840

-2,930

6,019

6,859

5,706

EBIT Margin

16.2%

5.05%

-17.99%

36.7%

39.7%

36.1%

Effective Tax Rate

46.72%

-95.75%

-20.06%

13.39%

14.2%

11.42%

Follow-Up Questions

What are Merck & Co Inc's key financial statements?



According to the latest financial statement (Form-10K), Merck & Co Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for MRK?



Merck & Co Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Merck & Co Inc's revenue broken down by segment or geography?



Merck & Co Inc largest revenue segment is Other, at a revenue of 10,446,000,000 in the most earnings release.For geography, United States is the primary market for Merck & Co Inc, at a revenue of 36,510,000,000.

Is Merck & Co Inc profitable?



no, according to the latest financial statements, Merck & Co Inc has a net loss of $0

Does Merck & Co Inc have any liabilities?



no, Merck & Co Inc has liability of 0

How many outstanding shares for Merck & Co Inc?



Merck & Co Inc has a total outstanding shares of 0

Merck & Co Inc (MRK) Financial

MRK Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is MRK?

Merck & Co Inc (MRK) Financial

MRK Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is MRK?

MRK Income

Follow-Up Questions

What are Merck & Co Inc's key financial statements?

What are the key financial ratios for MRK?

How is Merck & Co Inc's revenue broken down by segment or geography?

Is Merck & Co Inc profitable?

Does Merck & Co Inc have any liabilities?

How many outstanding shares for Merck & Co Inc?